Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL514764 | 1.00 | TGFBR1 (0.41) | TGFBR1ALDH1A1TRPA1TDP1TSHR | |
| Methacrylic Acid SCHEMBL3974705 | 1.00 | TGFBR1 (0.41) | TGFBR1ALDH1A1TRPA1TDP1TSHR | |
| Methacrylic Acid SCHEMBL4158756 | 1.00 | TGFBR1 (0.41) | TGFBR1ALDH1A1TRPA1TDP1TSHR | |
| Methacrylic Acid SCHEMBL497292 | 0.91 | TRPA1 (0.40) | TGFBR1ALDH1A1TRPA1 | |
| Methacrylic Acid SCHEMBL147269 | 0.87 | TGFBR1 (0.45) | TGFBR1ALDH1A1TDP1TSHR | |
| Methacrylic Acid SCHEMBL9815885 | 0.87 | TGFBR1 (0.45) | TGFBR1ALDH1A1TDP1TSHR | |
| Methacrylic Acid SCHEMBL472593 | 0.87 | TGFBR1 (0.45) | TGFBR1ALDH1A1TDP1TSHR | |
| Methacrylic Acid SCHEMBL5595699 | 0.87 | TGFBR1 (0.45) | TGFBR1ALDH1A1TDP1TSHR | |
| Acetic Acid SCHEMBL6419060 | 0.85 | ALDH1A1 (0.46) | TGFBR1ALDH1A1TRPA1TDP1LMNA | |
| Acetic Acid SCHEMBL5373299 | 0.85 | ALDH1A1 (0.46) | TGFBR1ALDH1A1TRPA1TDP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4028478-B1 | METHOD OF COATING A SUBSTRATE USING AN ACCELERATOR-FREE COATING COMPOSITION | AKZO NOBEL COATINGS INT BV (NL) | 2024-04-17 | — | — | EP | disclosed |
| US-11822243-B2 | Negative-type photosensitive resin composition, cured film, element and display device provided with cured film, and production method therefor | TORAY INDUSTRIES, INC. (JP) | 2023-11-21 | — | — | US | disclosed |
| EP-4028478-A1 | METHOD OF COATING A SUBSTRATE USING AN ACCELERATOR-FREE COATING COMPOSITION | Akzo Nobel Coatings International B.V. (NL) | 2022-07-20 | — | — | EP | disclosed |
| US-20220162366-A1 | POLYMERISABLE COMPOSITION FOR BONDING FIBRE UNITS | RUDOLF GMBH (DE) | 2022-05-26 | — | — | US | disclosed |
| WO-2021048293-A1 | METHOD OF COATING A SUBSTRATE USING AN ACCELERATOR-FREE COATING COMPOSITION | AKZO NOBEL COATINGS INTERNATIONAL B.V. (NL) | 2021-03-18 | — | — | WO | disclosed |
| US-20190258164-A1 | NEGATIVE-TYPE PHOTOSENSITIVE RESIN COMPOSITION, CURED FILM, ELEMENT AND DISPLAY DEVICE PROVIDED WITH CURED FILM, AND PRODUCTION METHOD THEREFOR | TORAY INDUSTRIES, INC. (JP) | 2019-08-22 | — | — | US | disclosed |
| EP-2960291-B1 | CROSSLINKING AID AND PRACTICAL APPLICATION THEREOF | MITSUBISHI CHEM CORP (JP) | 2018-12-26 | — | — | EP | disclosed |
| EP-2960265-B1 | CROSSLINKING RESIN COMPOSITION AND SEALING MEDIUM | MITSUBISHI CHEM CORP (JP) | 2018-11-14 | — | — | EP | disclosed |
| US-9932471-B2 | Crosslinking resin composition and sealing material | NIPPON KASEI CHEMICAL COMPANY LIMITED (JP) | 2018-04-03 | — | — | US | disclosed |
| US-20180002562-A1 | LOW-TEMPERATURE-CURABLE CROSS-SECTION REPAIR MATERIAL, AND CROSS-SECTION REPAIRING METHOD USING THE SAME | SHOWA DENKO K.K. (JP) | 2018-01-04 | — | — | US | disclosed |
| EP-2302008-A1 | Pigment dispersion and ink composition using the same | FUJIFILM Corporation (JP) | 2011-03-30 | — | — | EP | disclosed |
| US-7862163-B2 | Image forming method and image forming apparatus | FUJIFILM CORPORATION (JP) | 2011-01-04 | — | — | US | disclosed |
| US-7806514-B2 | Inkjet recording apparatus | FUJIFILM CORPORATION (JP) | 2010-10-05 | — | — | US | disclosed |
| US-20100137509-A1 | PIGMENT DISPERSION AND INK COMPOSITION USING THE SAME | FUJIFILM CORPORATION (JP) | 2010-06-03 | — | — | US | disclosed |
| EP-2130881-A1 | Pigment dispersion and ink composition using the same | FUJIFILM Corporation (JP) | 2009-12-09 | — | — | EP | disclosed |
| US-7501405-B2 | Combination therapy using an 11β-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders | HIGH POINT PHARMACEUTICALS, LLC (US) | 2009-03-10 | — | — | US | disclosed |
| US-20080018695-A1 | Inkjet recording apparatus | FUJIFILM CORPORATION | 2008-01-24 | — | — | US | disclosed |
| US-20080012887-A1 | Image forming method and image forming apparatus | FUJIFILM CORPORATION | 2008-01-17 | — | — | US | disclosed |
| US-20060111348-A1 | Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders | NOVO NORDISK A/S (DK) | 2006-05-25 | — | — | US | disclosed |
| US-6641911-B1 | Use of selected adhesive mixtures for overlap adhesion of round labels when applied to plastic bottles | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111348-A1 | Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders | HSD11B1, HSD11B2, HSD17B1 | TGFBR1 2008/4885ALDH1A1 74/4885TRPA1 4848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.